From the Food and Drug Administration.
McClellan
Mark B
MB
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000077384:Anastrozole; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D009570:Nitriles / Q000627:therapeutic use*; D063065:Organophosphonates; D014230:Triazoles / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D018931:Antineoplastic Agents, Hormonal; D000998:Antiviral Agents; D009570:Nitriles; D063065:Organophosphonates; D014230:Triazoles; D000077384:Anastrozole; D000225:Adenine; C106812:adefovir dipivoxil